help me understand handling, I have read the wiki twice
Question in the title, detail here: help me understand handling, I have read the wiki twice.
Research-use-only material is not approved for human use. In this catalogue that covers essentially everything, which is why the board discusses material and analytics rather than outcomes.
Asked ERP which lines they keep in regional stock versus make to order and got a clear split. It changed what I ordered.
Sent an unusual compound to Medutest because nobody on this site had ever posted one. 99.6% against a claimed 99.0%.
Happy to answer the boring questions. Those are usually the ones worth asking.
best — the order this archive was captured in
Storage guidance that names a temperature, a state and a duration reflects actual stability work. Generic guidance usually reflects a template.
Ordered under a name that turned out to cover two different molecules. Nobody’s fault but mine for not asking.
What storage conditions did they specify?
I would not treat catalogue breadth as a quality signal. It is a business decision, not an analytical one.
Stocked lines and made-to-order lines have different lead times and different storage histories. Both are ordinary; the difference is worth confirming before you commit.
For any compound with a thin testing history, identity is the first question. Mass spectrometry against a theoretical mass answers it; an area-percent purity figure does not.
Careful — that is a claim about efficacy and there is essentially no human evidence behind it.
Asked for a catalogue number rather than removing. Common names are ambiguous here and it makes threads unusable later.
Asked for identity confirmation on an unusual line and got a mass spectrum with the theoretical mass alongside. That is the answer I now look for everywhere.